miR-145 mediates the antiproliferative and gene regulatory effects of vitamin D3 by directly targeting E2F3 in gastric cancer cells

Oncotarget

Volumn 6, Issue 10, 2015, Pages 7675-7685

  Chang, Su'e ^a   Gao, Ling ^a   Yang, Yang ^a   Tong, Dongdong ^a   Guo, Bo ^a   Liu, Liying ^a   Li, Zongfang ^a   Song, Tusheng ^a   Huang, Chen ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

1,25(OH)2D3; E2F3; Gastric cancer; MiR 145; Proliferation

Indexed keywords

CALCITRIOL; COLECALCIFEROL; CYCLIN A2; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 6; MICRORNA 145; TRANSCRIPTION FACTOR E2F3; VITAMIN D RECEPTOR; CALCITRIOL RECEPTOR; E2F3 PROTEIN, HUMAN; MICRORNA; MIRN145 MICRORNA, HUMAN;

ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CANCER PROGNOSIS; CCNA2 GENE; CDK2 GENE; CDK6 GENE; CELL VIABILITY; COLONY FORMATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG TARGETING; E2F3 GENE; GASTRIC CANCER CELL LINE; GENE; GENE CONTROL; GENE REPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; INHIBITION KINETICS; PROTEIN EXPRESSION; PROTEIN INDUCTION; S PHASE CELL CYCLE CHECKPOINT; STOMACH CANCER; CELL PROLIFERATION; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; STOMACH TUMOR; TUMOR CELL LINE;

CALCITRIOL; CELL LINE, TUMOR; CELL PROLIFERATION; E2F3 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MICRORNAS; RECEPTORS, CALCITRIOL; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS; TRANSFECTION;

EID: 84928396836     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.3048     Document Type: Article

References (45)

1. Sacconi A, et al. miR-204 targets Bcl-2 expression andenhances responsiveness of gastric cancer. Cell Death Dis. 2012; 3:e423.
2. Feldman D, et al. The role of vitamin D in reducing cancer risk and progression. Nat Rev Cancer. 2014; 14:342-57.
3. Vanoirbeek E, et al. PDLIM2 expression is driven by vitamin D and is involved in the pro-adhesion, and anti-migration and-invasion activity of vitamin D. Oncogene. 2014; 33:1904-11.
4. Pilon C, et al. 1alpha,25-Dihydroxyvitamin D(3) inhibits the human H295R cell proliferation by cell cycle arrest: a model for a protective role of vitamin D receptor against adrenocortical cancer. J Steroid Biochem Mol Biol. 2014; 140:26-33.
5. Thyer L, et al. A novel role for a major component of the vitamin D axis: vitamin D binding protein-derived macrophage activating factor induces human breast cancer cell apoptosis through stimulation of macrophages. Nutrients. 2013; 5:2577-89.
6. Zhang Y, et al. VDR status arbitrates the prometastatic effects of tumor-associated macrophages. Mol Cancer Res. 2014; 12:1181-91.
7. Zitman-Gal T, et al. Vitamin D manipulates miR-181c, miR-20b and miR-15a in human umbilical vein endothelial cells exposed to a diabetic-like environment. Cardiovasc Diabetol. 2014; 13:8.
8. Min D, et al. Downregulation of miR-302c and miR-520c by 1,25(OH)2D3 treatment enhances the susceptibility of tumour cells to natural killer cell-mediated cytotoxicity. Br J Cancer. 2013; 109:723-30.
9. Padi SK, et al. MicroRNA-627 mediates the epigenetic mechanisms of vitamin D to suppress proliferation of human colorectal cancer cells and growth of xenograft tumors in mice. Gastroenterology. 2013; 145:437-46.
10. Wang L, et al. MicroRNA-302b suppresses cell proliferation by targeting EGFR in human hepatocellular carcinoma SMMC-7721 cells. BMC cancer. 2013; 13:448.
11. Yang Q, et al. Genetic variations in miR-27a gene decrease mature miR-27a level and reduce gastric cancer susceptibility. Oncogene. 2014; 33:193-202.
12. Takei Y, et al. The metastasis-associated microRNA miR-516a-3p is a novel therapeutic target for inhibiting peritoneal dissemination of human scirrhous gastric cancer. Cancer Res. 2010; 71:1442-53.
13. Wu Q, et al. MiR-19b/20a/92a regulates the self-renewal and proliferation of gastric cancer stem cells. J Cell Sci. 2013; 126:p. 4220-4229.
14. Shin VY, et al. NF-kappaB targets miR-16 and miR-21 in gastric cancer: involvement of prostaglandin E receptors. Carcinogenesis. 2010; 32:240-5.
15. Shang Y, et al. miR-508-5p regulates multidrug resistance of gastric cancer by targeting ABCB1 and ZNRD1. Oncogene. 2014; 33:3267-3276.
16. Lin Y, et al. Genetic polymorphism at miR-181a binding site contributes to gastric cancer susceptibility. Carcinogenesis. 2012; 33:2377-83.
17. Guo B, et al. miR-338-3p Suppresses Gastric Cancer Progression through a PTEN-AKT Axis by Targeting P-REX2a. Molecular Cancer Research. 2014; 12:313-321.
18. Ren C, et al. Prognostic effects of 25-hydroxyvitamin D levels in gastric cancer. J Transl Med. 2012; 10:16.
19. Pan LN, et al. Vitamin D stimulates apoptosis in gastric cancer cells in synergy with trichostatin A/sodium butyrateinduced and 5-aza-2 '-deoxycytidine-induced PTEN upregulation. Febs Journal. 2010; 277:989-999.
20. Yao Y, et al. MicroRNA profiling of human gastric cancer. Mol Med Rep. 2009; 2:963-70.
21. Ting HJ, et al. Identification of microRNA-98 as a therapeutic target inhibiting prostate cancer growth and a biomarker induced by vitamin D. J Biol Chem. 2013; 288:1-9.
22. Alvarez-Diaz S, et al. MicroRNA-22 is induced by vitamin D and contributes to its antiproliferative, antimigratory and gene regulatory effects in colon cancer cells. Hum Mol Genet. 2012; 21:2157-65.
23. Bilinski K, Boyages J. Association between 25-hydroxyvitamin D concentration and breast cancer risk in an Australian population: an observational case-control study. Breast Cancer Res Treat. 2013; 137:599-607.
24. Hibler EA, et al. Associations between circulating 1,25(OH) (2)D concentration and odds of metachronous colorectal adenoma. Cancer Causes Control. 2014; 25:809-17.
25. Holt SK, et al. Circulating levels of 25-hydroxyvitamin D and prostate cancer prognosis. Cancer Epidemiol. 2013; 37:666-70.
26. Pan L, et al. Vitamin D stimulates apoptosis in gastric cancer cells in synergy with trichostatin A/sodium butyrateinduced and 5-aza-2'-deoxycytidine-induced PTEN upregulation. FEBS J. 2010; 277:989-99.
27. Adams JS, et al. Regulation of the extrarenal CYP27B1-hydroxylase. J Steroid Biochem Mol Biol. 2014; 144:22-7.
28. Kasiappan R, et al. 25-Dihydroxyvitamin D3 Suppresses Telomerase Expression and Human Cancer Growth through MicroRNA-498. Journal of Biological Chemistry. 2012; 287:4297-4309.
29. Gocek E, et al. MicroRNA-32 upregulation by 1,25-dihydroxyvitamin D3 in human myeloid leukemia cells leads to Bim targeting and inhibition of AraC-induced apoptosis. Cancer Res. 2011; 71:6230-9.
30. Wang X, et al. MicroRNAs11 regulate the expression of p27Kip1 in human myeloid leukemia cells induced to differentiate by 1,25-dihydroxyvitamin D3. Cell Cycle. 2009; 8:736-41.
31. Yu CC, et al. miR145 Targets the SOX9/ADAM17 Axis to Inhibit Tumor-Initiating Cells and IL-6-Mediated Paracrine Effects in Head and Neck Cancer. Cancer Res. 2013; 73:3425-3440.
32. Noh JH, et al. MiR-145 functions as a tumor suppressor by directly targeting histone deacetylase 2 in liver cancer. Cancer Lett. 2013; 335:455-62.
33. Doberstein K, et al. MicroRNA-145 targets the metalloprotease ADAM17 and is suppressed in renal cell carcinoma patients. Neoplasia. 2013; 15:218-30.
34. Avgeris M, et al. The loss of the tumour-suppressor miR-145 results in the shorter disease-free survival of prostate cancer patients. British Journal of Cancer. 2013; 108:2573-2581.
35. Zheng L, et al. miRNA-145 targets v-ets erythroblastosis virus E26 oncogene homolog 1 to suppress the invasion, metastasis, and angiogenesis of gastric cancer cells. Mol Cancer Res. 2013; 11:182-93.
36. Bauer KM, Hummon AB. Effects of the miR-143/-145 microRNA cluster on the colon cancer proteome and transcriptome. J Proteome Res. 2012; 11:4744-54.
37. Xing AY, et al. Deregulated expression of miR-145 in manifold human cancer cells. Experimental and Molecular Pathology. 2013; 95:91-97.
38. Zhu H, et al. EGFR signals downregulate tumor suppressors miR-143 and miR-145 in Western diet-promoted murine colon cancer: role of G1 regulators. Mol Cancer Res. 2011; 9:960-75.
39. Oeggerli M, et al. E2F3 amplification and overexpression is associated with invasive tumor growth and rapid tumor cell proliferation in urinary bladder cancer. Oncogene. 2004; 23:5616-23.
40. Miles WO, et al. Pumilio facilitates miRNA regulation of the E2F3 oncogene. Genes Dev. 2012; 26:356-68.
41. Feng B, et al. MicroRNA-200b reverses chemoresistance of docetaxel-resistant human lung adenocarcinoma cells by targeting E2F3. Cancer. 2012; 118:3365-3376.
42. Huang L, et al. MicroRNA-125b suppresses the development of bladder cancer by targeting E2F3. Int J Cancer. 2011; 128:1758-69.
43. Humbert PO, et al. E2f3 is critical for normal cellular proliferation. Genes Dev. 2000; 14:690-703.
44. Bueno MJ, et al. Multiple E2F-induced microRNAs prevent replicative stress in response to mitogenic signaling. Mol Cell Biol. 2010; 30:2983-95.
45. Gao L, et al. IGF-1R, a target of let-7b, mediates crosstalk between IRS-2/Akt and MAPK pathways to promote proliferation of oral squamous cell carcinoma. Oncotarget. 2014; 5:2562-2574.